FDA Change In Bioequivalence Requirements Leads To Downgrade Of Accord’s Generic Tacrolimus

 
• By Brenda Sandburg
  
Downgrade
FDA downgrades the therapeutic equivalence rating of Accord Healthcare's tacrolimus generic drug product • Source: Shutterstock

More from Generics

More from Biosimilars & Generics